Clarivate Plc (NYSE:CLVT) Given Consensus Recommendation of “Hold” by Brokerages

Clarivate Plc (NYSE:CLVTGet Free Report) has been assigned a consensus rating of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $7.78.

Separately, The Goldman Sachs Group dropped their price target on Clarivate from $8.50 to $7.50 and set a “buy” rating on the stock in a research note on Thursday, May 9th.

Read Our Latest Research Report on Clarivate

Institutional Trading of Clarivate

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Exor N.V. grew its holdings in shares of Clarivate by 2.4% in the first quarter. Exor N.V. now owns 67,294,884 shares of the company’s stock valued at $500,001,000 after acquiring an additional 1,566,519 shares in the last quarter. Impactive Capital LP grew its holdings in Clarivate by 0.3% during the first quarter. Impactive Capital LP now owns 37,887,185 shares of the company’s stock valued at $281,502,000 after purchasing an additional 109,247 shares during the period. Baupost Group LLC MA grew its holdings in Clarivate by 20.0% during the first quarter. Baupost Group LLC MA now owns 30,598,402 shares of the company’s stock valued at $227,346,000 after purchasing an additional 5,098,402 shares during the period. Glenview Capital Management LLC grew its holdings in Clarivate by 22.2% during the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock valued at $228,269,000 after purchasing an additional 4,472,302 shares during the period. Finally, Vanguard Group Inc. grew its holdings in Clarivate by 2.2% during the third quarter. Vanguard Group Inc. now owns 7,986,939 shares of the company’s stock valued at $53,592,000 after purchasing an additional 171,326 shares during the period. 85.72% of the stock is owned by institutional investors.

Clarivate Trading Down 2.8 %

NYSE CLVT opened at $5.53 on Tuesday. The business’s 50-day moving average price is $6.05 and its two-hundred day moving average price is $7.48. Clarivate has a 12 month low of $5.19 and a 12 month high of $10.03. The firm has a market capitalization of $3.70 billion, a PE ratio of -3.33, a price-to-earnings-growth ratio of 3.84 and a beta of 1.15. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.03.

Clarivate (NYSE:CLVTGet Free Report) last released its quarterly earnings results on Wednesday, May 8th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.02. Clarivate had a positive return on equity of 10.11% and a negative net margin of 39.29%. The firm had revenue of $621.20 million for the quarter, compared to analyst estimates of $614.57 million. On average, analysts expect that Clarivate will post 0.62 EPS for the current year.

Clarivate Company Profile

(Get Free Report

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

See Also

Analyst Recommendations for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.